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Processing of fibrillar collagens is required to generate collagen monomers able to self-assemble into elongated 
and cylindrical collagen fibrils. ADAMTS-2 belongs to the "A disintegrin and metalloproteinase with 
thrombospondin type 1 motifs" (ADAMTS) family. It is responsible for most of the processing of the 
aminopropeptide of type I procollagen in the skin, and it also cleaves type II and type III procollagens. 
ADAMTS are complex secreted enzymes that are implicated in various physiological and pathological 
processes. Despite accumulating evidence indicating that their activity is regulated by ancillary domains, 
additional information is required for a better understanding of the specific function of each domain. We have 
generated 17 different recombinant forms of bovine ADAMTS-2 and characterized their processing, activity, and 
cleavage specificity. The results indicated the following: (i) activation of the ADAMTS-2 zymogen involves 
several cleavages, by pro-protein convertases and C-terminal processing, and generates at least seven distinct 
processed forms; (ii) the C-terminal domain negatively regulates enzyme activity, whereas two thrombospondin 
type 1 repeats are enhancer regulators; (iii) the 104-kDa form displays the highest aminoprocollagen peptidase 
activity on procollagen type I; (iv) ADAMTS-2 processes the aminopropeptide of α1 type V procollagen 
homotrimer at the end of the variable domain; and (v) the cleaved sequence (PA) is different from the previously 
described sites ((P/A)Q) for ADAMTS-2, redefining its cleavage specificity. This finding and the existence of 
multiple processed forms of ADAMTS-2 strongly suggest that ADAMTS-2 may be involved in function(s) other 
than processing of fibrillar procollagen types I-III. 
 
Collagens types I-III are synthesized as precursors (procollagens) formed by a central triple helical collagen 
domain extended by propeptides at both extremities. Removal of the C-propeptide,1 by BMP-1 and related 
enzymes, and the N-propeptide, by aminoprocollagen peptidases (ADAMTS-2, -3, or -14), is required to 
generate collagen monomers able to assemble spontaneously into elongated and cylindrical collagen fibrils. It 
has been shown in vitro and in vivo that ADAMTS-2 is the enzyme responsible for most of the 
aminoprocollagen type I processing in the skin (1-3), although it was suggested that an essential function of 
ADAMTS-3 is the processing of aminoprocollagen type II in cartilage (4). A closely related enzyme, ADAMTS-
14, also displays aminoprocollagen peptidase activity (5). More recently, it has been shown that ADAMTS-2 is 
also able to process aminoprocollagen type III in vitro (6). Type V collagen is a minor fibrillar collagen. Among 
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  The abbreviations used are: C-propeptide, C-terminal propeptide; ADAMTS, A disintegrin-like and metalloproteinase with 
thrombospondin type I repeats; N-propeptide, N-terminal propeptide; BMP-1, bone morphogenic protein-1; DMEM, Dulbecco's modified 
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the four different individual collagen type V chains, α1 is the most abundant and ubiquitous and can be found as 
a homotrimer or as a heterotrimer in association with type V or type XI a chains (7,8). Its maturation from 
procollagen to collagen is reported to be different from what is observed for procollagens I-III, because the C-
propeptide can be cleaved by furin (9, 10) and/or by BMP-1 (11, 12) depending on the chain type. In addition, 
the N-propeptide does not seem to be processed by aminoprocollagen peptidases. Instead, BMP-1 cleavage has 
been reported between the proline/arginine-rich protein domain and the variable domain of the α1 chain (9) and 
between the small and the large collagenous domain of α3 chain (10). 
ADAMTS proteases are complex secreted enzymes that contain a reprolysin-type pro-metalloproteinase domain 
attached to ancillary domains with highly conserved structures, including at least one thrombospondin type 1 
repeat (13). As for matrix metalloproteinases and ADAMs, the control of their enzymatic activity can be exerted 
at multiple points, including transcription, translation, zymogen activation, and inhibition by specific natural 
inhibitors. For most ADAMTS enzymes, the N-terminal domain is cleaved by furin or a related enzyme (6, 14). 
In addition, proteolytic processing in the ancillary domains of some ADAMTS has been reported (15), increasing 
or inhibiting their enzymatic activity (16). However, the implication of the various domains for enzyme activity 
and substrate specificity remains largely unknown. Similarly, additional studies are required for a better 
understanding of the mechanisms of ADAMTS activation and for the identification of enzymes responsible for 
ADAMTS processing. 
In this work, various forms of bovine recombinant ADAMTS-2, either full size, lacking specific domains, or 
mutated at specific sites, were produced. They have been used to determine the specific role of individual 
domains for aminoprocollagen type I peptidase activity, to characterize the activation process of the 
zymogenform of ADAMTS-2, and to evaluate the enzymatic activity of ADAMTS-2 on aminoprocollagen type 
V. 
MATERIALS AND METHODS 
Restriction enzymes, Pwo DNA polymerase, hygromycin B, FuGENE 6 transfection reagent, α2-macroglobulin, 
and anti-HA rat antibody were from Roche Diagnostics; ligase (DNA Ligation kit version 2) was from Takara 
Biomedicals (Shiga, Japan). Competent bacteria (XL-Gold® Ultracompetent Cells) and QuickChange™ XL site-
directed mutagenesis kit were from Stratagene (Cedar Creek, TX). pCEP4 vector, DMEM culture medium, and 
DM1™ competent cells used for preparation of plasmid requiring BclI digestion were from Invitrogen. Fetal 
bovine serum was from Cambrex (Verviers, Belgium); the ECL detection system was from Amersham 
Biosciences, and the anti-FLAG™ M2 mouse monoclonal antibody used for Western blotting was from Sigma. 
The gon-1 cDNA was the kind gift of J. Kimble (17). 
Creation of the Various Expression Vectors and Cell Transfection— For the creation of construct 1, a vector 
containing the bovine ADAMTS2 cDNA (18) was digested at the NotI and HindIII sites (Fig. 1A). The released 
insert was then subcloned in a pCDNA3 vector containing a modified multiple cloning site. The 3'-end of the 
cDNA was PCR-amplified with Pwo DNA polymerase using primer A as forward primer (5'-
CTACAAGGACGCCTTCAGCCTCT-3') and primer B containing NheI- and XbaI-specific sequences at its 5'-
end as reverse primer (5'-CTCTTCTAGATTAGCTAGCGAACTTTCCGAGCAT-CTCTTTCTTC-3'). After 
HindIII/XbaI digestion, the PCR product was ligated downstream from the NotI/HindIII insert. The construct 
was then linearized at the NheI site in order to introduce a double-stranded adaptor (sense, 5'-
CTAGCGATTATAAAGATGACGATG-ACAAATAA-3', and reverse, 5'-CTAGTTATTTGTCATCGTCAT-
CTTTATAATCG-3') coding for an M2-FLAG (DYKDDDDK) followed by a TAA stop codon. Because of its 
design, ligation of the adaptor restored an NheI site only at its 5'-end. Finally, the construct was digested 
(NotI/XbaI), and the insert containing the M2-FLAG at its 3'-end was ligated in the NotI/NheI site of a modified 
pCEP4 vector. Constructs 2-5 were obtained by replacing the HindIII/NheI cassette of construct 1 by PCR 
products amplified using primer A as forward primer and primers C(5'-
CTCTTCTAGATTAGCTAGCTAGCCAC-TGGACCACGTAGCTCT-3'), D (5'-CTCTTCGCTAGCAGGGCA-
CAGCTCGCGGTTGCA-3'), E (5'-CTCTTCGCTAGCGGAGCAC-TCCTGTGGGTTGCA-3'), or F (5'-
CTCTTCTAGATTAGCTAGC-CTCATAGCCCACAGAGTCGTCTT-3') as reverse primers. Construct 6 was 
created by using a QuickChange™ XL site-directed mutagenesis kit and two mutagenic primers (M, 5'-
GTTCGTGGTGGCCC-ACGCGACTGGCCATGTGCTGG-3', and N, 5'-CCAGCACATGG-
CCAGTCGCGTGGGCCACCACGAAC-3') changing the GAG codon for Glu of the Zn2+-binding catalytic site 
(HETGH) into a GCG codon for Ala. For constructs 8-10, the EcoRI/HindIII fragment of construct 1 was 
removed and replaced by PCR products amplified using J (5'-GGATCTCAAACATCTTGATGTAACCA-3') as 
reverse primer and primers G (5'-CACAGAATTCCATGCTGCCGACGACGACTA-CAAC-3'), H (5'-
CACAGAATTCGGGAACCCCTCTCAAAGTCT-GGA-3'), and I (5'-
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CACAGAATTCACGCTGAACCACGAGGACG-GCTT-3 ') as forward primers, each of them containing an 
EcoRI site at their 5'-end. For construct 7, the vector containing construct 8 was linearized at the EcoRI site, 
allowing the ligation of an EcoRI-digested PCR product amplified with primers K (5'-TTTGGCCGAGACCTG-
CACCTGC-3') and L (5'-CACAGAATTCCATACTCCGCCTG-GAGCTGTTGA-3') containing an EcoRI site at 
their 5'-end. Primer L was also designed in order to change the sequence coding for a furin cleavage site 
(RRRMRR) into a sequence coding for an unrelated amino acid sequence (FEMSRR). For construct 11, the 
BclI/HindIII fragment of construct 1 was removed. After incubation with Pwo DNA polymerase and dNTP in 
order to generate blunt ends, the vector was self-ligated. This introduced a large deletion but did not change the 
open reading frame of the remaining coding sequence. For constructs 12 and 13, construct 1 was digested by 
HindIII/NheI or BcII/HindIII, respectively, and the deleted sequences were replaced by corresponding domains 
amplified from gon-1 cDNA using primers O (5'-CACACAG-
CTAGCTCTTGGACATGGAATTCTGTTACATTC-3')and P(5'-C-
ACACAAAGCTTGGTTATAACGAAGTAATGAAGATTCCA-3'), or Q (5'-
CACACAAAGCTTTCCTTGCTCATTAAATGTTCCTTT-GA-3') and R (5'-
CACAGGATCCTGTCCAACATCATGACGTTG-CAATC-3'). Construct 14 coding for ADAMTS-14 was as 
described earlier (5), and constructs 15-17 were obtained by exchanging the homologous coding sequences of 
ADAMTS2 and ADAMTS14 by restriction enzyme digestion and ligation. Additional constructs were also created 
by introducing, in-frame, a double-stranded adaptor (forward, 5'-
AGCTATATCCTTACGATGTTCCTGACTATGCTA-3'; reverse, 5'-
AGCTTAGCATAGTCAGGAACATCGTAAGGATAT-3') coding for an HA-FLAG (YPYDVPDYA) in the 
HindIII site of 9 vectors (1, 2, 5-7,14 -17). These modified constructs (not shown) will be designated in the paper 
as constructs 1A, 2A, 5A to 7A, and 14A to 17A. This 9-amino acid insertion does not modify the level of 
expression or the enzymatic activity of the various forms of the recombinant enzymes. 
The various expression vectors were used to transfect different cell lines (HT 1080 fibrosarcoma cells, WI26 
immortalized lung fibroblasts, COS, Balb, MCF7, SaOS2 osteosarcoma cells, 293EBNA epithelial kidney cells) 
by using FuGENE 6 according to the manufacturer's recommendations. Stable cell lines were then selected in 
DMEM culture medium supplemented with 10% fetal calf serum and 200 µg/ml hygromycin. 
Cell Culture and Treatment—Stably transfected cells expressing the various constructs were cultured in 
DMEM supplemented with fetal calf serum and hygromycin. At confluence, the growth medium was removed, 
and the cells were maintained in DMEM alone or containing specific chemicals or inhibitors at the indicated 
concentrations. After 24 or 48 h, the different media were collected, and the cells were scraped and extracted for 
2 h in extraction buffer (50 mM Tris, pH 7.5; 500 mM NaCl; 2 mM CaCl2; 25 mM NEM; 1 mM PMSF). After 
centrifugation, the cell extracts were collected (cell extract 1), and the pellets were solubilized in SDS-PAGE 
denaturation buffer containing 100 mM DTT (cell extract 2). 
For correlation studies comparing the levels of each individual band of enzyme to the aminoprocollagen 
peptidase activity, 293 cells expressing various constructs were cultured for 24 h in medium supplemented with 
0.1 or 5% fetal calf serum alone (control conditions) or containing additional chemicals (EDTA at 0.04,0.2, or 1 
mM; ZnCl2 at 16 or 80 µM; CuCl2 at 16 or 80 µM; heparin at 1, 5, or 25 µg per ml; decanoyl-RVKR (furin 
inhibitor) at 10, 20, or 40 µM; L-arginine at 25, 50, or 100 mM). 
Compartmentalization Studies—Dermatosparactic calf fibroblasts, cells that do not synthesize ADAMTS-2, 
were grown to confluence (duplicate culture, 24-wells culture plates) in DMEM supplemented with 10% fetal 
calf serum. Cells were then incubated at 4 °C in 400 µl of medium containing or not heparin (5 µg/ml) and 
recombinant purified ADAMTS-2 (10 µg/ml). After 6 h, medium was removed, and the cell layer was denatured 
in Laemmli sample buffer containing 0.1 M DTT. Western blot analysis using mAb23 was then performed to 
determine the proportion of ADAMTS-2 bound to the cell layer. 
FIGURE 1. Creation of the various forms of recombinant ADAMTS-2. A, localization of the introduced or 
endogenous restriction sites is illustrated above the schematic representation of ADAMTS2 cDNA. Position of 
the primers used for the creation of the various constructs and their 5' to 3' orientation are illustrated by arrows. 
B represents the schematic domain organization of ADAMTS-2. The localization of the Zn2+-binding catalytic 
site and potential cleavage sites by furin [Fur) are illustrated. Position of epitopes recognized by the different 
antibodies and size of the various domains, expressed by amino acid number, are also indicated. *, the cleavage 
site of the signal peptide was not exactly determined. From amino acid sequence analysis, cleavage is expected 
to occur 30-40 amino acids downstream of the initial methionine residue. Accordingly, the exact size of the 
prodomain could not be determined. **, HA FLAG coding sequence was introduced in the Hindlll restriction site 
of constructs 1, 2, 5-7, and 14-16. These HA-flagged constructs are designated as constructs 1A, 2A, 5A-7A, and 
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14A-17A in the text. Domain structure organization of the various forms of ADAMTS-2 is illustrated in C. Dotted 
lines represent internal lacking sequences and arrowheads localization of point mutations. For chimeric 
enzymes 12 and 13, domains of GON-1 are in black, and arrows represent position of the gon-1-specific 
oligonucleotides used to create the constructs. Constructs coding for ADAMTS-14 [construct 14) or ADAMTS-
2/ADAMTS-14 chimeric enzymes [constructs 15-17) were created by restriction enzyme digestion and ligation. 
Domains originating from ADAMTS-14 are in black. 
 
Large Scale Purification of Enzyme—For large scale purification of recombinant enzymes, 100 Petri dishes of 
stably transfected cells were grown in DMEM supplemented with 10% fetal calf serum and hygro-mycin. At 
confluence, medium was removed and replaced by serum-free DMEM containing soybean trypsin inhibitor (40 
µg/ml), heparin (5 µg/ml), and ZnCl2 (80 µM). After 48 h, the conditioned medium was collected, concentrated, 
and loaded on a 25-ml concanavalin A-Sepha-rose column pre-equilibrated in buffer A (50 mM Tris, pH 7.5; 1M 
NaCl; 2 mM CaCl2). After washing with buffer A, elution was carried out in the same buffer containing 500 mM 
α-methyl-D-mannoside. Fractions containing the recombinant enzyme were then dialyzed against buffer B (50 
mM Tris, pH 7.5; 0.2 M NaCl; 2 mM CaCl2) and loaded on a 5-ml heparin-Sepharose column. After washing in 
buffer B, elution was performed in buffer A. 
Antibody Preparation and Characterization—AS175 was obtained by immunizing a rabbit with recombinant 
ADAMTS-2 purified by SDS-PAGE. Although the immunization was performed with a full-length protein, the 
antiserum was specific for the C-terminal domain only, as determined by Western blotting using the various 
recombinant enzymes. For production of monoclonal antibody, mice were immunized with active and not 
denatured recombinant ADAMTS-2. Among the tested hybridoma, one (mAb23) produced an antibody (IgG2b) 
able to recognize native and denatured ADAMTS-2. By using the various recombinant enzymes, it was 
determined that this antibody is specific for the last TSPI repeat of ADAMTS-2. Further analysis showed that 
AS175 and mAb23 do not block the aminoprocollagen peptidase activity of ADAMTS-2 and do not display 
cross-reactivity with ADAMTS-3 and -14. 
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Characterization of the Various Recombinant Enzymes—The electrophoretic pattern of the various 
recombinant enzymes present in the conditioned media and in the two cell layer-associated fractions (see above) 
was determined by Western blotting analysis using antibodies specific for the M2- or HA-FLAG, the last TSPI 
repeat (mAb23), or the C-terminal domain (AS 175) of ADAMTS-2. The various samples of conditioned 
medium and cell extracts were also assayed for their aminoprocollagen peptidase activity (see below). In order to 
identify which forms of the enzyme were responsible for the processing of procollagen substrates, a correlation 
was calculated between the activity measured in the various samples and the relative abundance of each 
individual form of recombinant enzymes. 
Protein Deglycosylation—A crude cell extract containing all the ADAMTS-2 forms detected during our study 
was incubated with PNGase F or neuraminidase according to manufacturer's protocol. The electrophoretic 
pattern of ADAMTS-2 before and after treatment was determined by Western blotting using mAb23. 
FIGURE 2. Evaluation of recombinant ADAMTS-2 synthesis and activity at increasing time points after 
transfection. A 293EBNA cells collected 2-26 days after transfection by construct 1 were analyzed by Western 
blotting using anti M2-FLAG antibody. B, samples analyzed on A were further characterized by using mAb23, 
an antibody specific for the 4th TSPI repeat. C aminoprocollagen type peptidase activity of the corresponding 
cell extract was also determined and is expressed in counts/min of processed substrate. This assay allowed 
accurate and linear evaluation of enzyme activity in the range of 0-1500 cpm of processed substrate. A striking 
discrepancy was observed between the amount of ADAMTS-2 and the level of enzymatic activity. 
 
Protein Sequencing—For the determination of the N-terminal sequence of the various ADAMTS-2 
polypeptides, a highly purified preparation of recombinant enzyme (construct 1) was dialyzed against 1 M 
ammonium acetate, concentrated by lyophilization, and migrated in a pre-run 7% acrylamide/piperazine 
diacrylamide gel in 50 mM Tris borate buffer, pH 8.3, containing 0.1% SDS and 0.1 mM thioglycolic acid. After 
transfer on a polyvinylidene difluoride membrane (in Tris (50 mM)/borate; pH 8.5) and Coomassie Blue staining 
(in 40% methanol), the different bands were collected and submitted to six cycles of Edman degradation. For 
type V collagen sequencing, recombinant type V pNcollagen (19) was incubated for 18 h with highly purified 
recombinant ADAMTS-2 and processed as described above. Determination of the N-terminal sequence was 
performed only for the polypeptide generated by ADAMTS-2 digestion. 
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Purification of Type V Collagen from Bovine Skin—Skin, collected from fetal calves at the third trimester stage, 
was ground at liquid nitrogen temperature and homogenized with an Ultra Turrax (8000 rpm) in washing buffer 
(50 mM Tris-HCl, pH 7.5; 0.25 M sucrose; 2.5 mM NEM; 1 mM PMSF; and 2 mM EDTA). After centrifugation 
(20,000 x g), the pellets were collected, and the washing procedure was repeated once. Pellets were then 
suspended and rotated for 18 h at 4 °C in extraction buffer (50 mM Tris-HCl, pH 7.5; 2.5 mM NEM;1 mM 
PMSF; and 2 mM EDTA) containing 0.15 M NaCl. After centrifugation, supernatants were collected, and pellets 
were further sequentially extracted in the same buffer containing 1 M NaCl and in 0.1 M acetic acid. The various 
supernatants were dialyzed in 0.1 M acetic acid containing 0.7 M NaCl. After centrifugation (20,000 X g), a 
large amount of type I collagen was present in the pellets, whereas type V collagen remained in solution. 
Supernatants were then further dialyzed (0.1 M acetic acid, 1.2 M NaCl). After centrifugation, type V collagen 
was recovered in the pellet. Even in the most enriched fractions, type V collagen was recovered in low amounts 
(0.5 to 2% of total protein content, as judged after SDS-PAGE and Coomassie Blue staining), the most abundant 
protein being type I collagen. 
Inhibition of ADAMTS-2 Activity by α2-Macroglobulin—ADAMTS-2 (~ 10 ng, as determined by Coomassie 
Blue staining after SDS-PAGE) was preincubated for 1 h at 37 °C with α2-macroglobulin (25 units/ml, 1 unit (40 
µg) inhibiting 9.1 µg of trypsin in a standard assay) at varying concentrations (0.025 to 0.4 units). The 
aminoprocollagen type I was then added, and the peptidase activity was evaluated (see below). The bait and trap 
mechanism of inhibition of ADAMTS-2 by α2-macroglobulin, resulting in an electrophoretic band shift, was 
investigated by Western blotting using anti-HA-FLAG antibody. Two types of samples were used. In the first 
series, purified ADAMTS-2 was incubated alone or with α2-macroglobulin (0.1 unit) in the absence or presence 
of EDTA. The second series consisted of enzyme (constructs 1A, 2A, or 5A) secreted in culture medium 
supplemented with 10% fetal calf serum as a source for α2-macroglobulin. 
Procollagen Processing in Vitro—The aminoprocollagen peptidase activity of ADAMTS-2 was determined by 
using either 14C-labeled pNI collagen as substrate (20) or by evaluating the level of processing of unlabeled 
substrate by Western blotting. Briefly, purified bovine pNI (2 µg) or recombinant pNV homotrimer (0.2 µg) (19) 
was incubated at 26 °C with the various enzyme preparations as described previously (20). After 18 h, the 
samples were denatured and submitted to electrophoresis and were either stained with Coomassie Blue or 
transferred on polyvinylidene difluoride membrane. For Western blotting experiments, the pattern of collagen 
polypeptide was determined by using rabbit antiserum specific for type I or pepsinized type V (NOVOTEC, 
Lyon, France) collagen. 
RESULTS 
Expression of Recombinant Enzyme—Various cell lines were trans-fected with expression construct 1 (Fig. 1) 
or empty vector as control. Within a few days after transfection, large amounts of recombinant ADAMTS-2 were 
produced by most cell lines, as determined by Western blotting analysis of the cell lysate using an anti-M2 
FLAG antibody, but only very low levels of aminoprocollagen peptidase activity could be detected (not shown). 
Because 293 cells were identified as the cells producing the largest amount of active recombinant enzyme, other 
cell lines were not further used. During the selection process, the amount of recombinant enzyme progressively 
decreased, as judged from Western blotting analysis using anti-M2 FLAG antibody (Fig. 2A). Most surprisingly, 
enzymatic activity was not similarly altered (Fig. 2C). A moderate increase of activity was first observed, 
followed by a small decrease and a sharp increase after 3 weeks of selection. These data suggested that a 
maturation process was required for full activity. This hypothesis was confirmed by Western blotting analysis 
(Fig. 25), using a monoclonal antibody specific for the 4th TSPI repeat. 
In order to determine which domains of ADAMTS-2 are involved in the regulation of its activity, various 
recombinant variants (Fig. 1, constructs 2-17) were produced. In a first set of experiments, recombinant enzyme 
lacking either the PNP domain (construct 2) or the PNP domain and one, two, or three TSPI repeats (constructs 
3-5) were created. In a second set, the second potential cleavage site by furin was mutated (construct 7), or 
various portions of the region at the border between the pro-domain and the metalloproteinase domain were 
deleted (constructs 8-10). As negative controls, enzyme mutated at the catalytic site (construct 6) or lacking the 
central domains (construct 11) was also produced. Finally, as a third set of constructs, chimeric enzymes were 
produced by replacing domains of ADAMTS-2 by the corresponding domains of GON-1, a Caenorhabditis 
elegans ADAMTS (constructs 12 and 13), or of ADAMTS-14, an enzyme closely related to ADAMTS-2 but 
displaying only very low aminoprocollagen peptidase activity (constructs 15-17). All the recombinant proteins 
were synthesized, as determined by the detection of the M2-FLAG by Western blotting (Fig. 3A). The presence 
of a second low molecular weight band for constructs 1-4 and its absence for constructs 7-10 strongly suggested 
that ADAMTS-2 was processed at the furin cleavage site. However, no processing was observed for constructs 
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5,11-13, and 14-17. As an additional observation, we showed that the M2-FLAG at the C terminus of the various 
recombinant proteins was progressively degraded and that the level of degradation varied from one recombinant 
protein to another, preventing reliable and reproducible quantifications of the recombinant protein by Western 
blotting using the anti-M2 FLAG antibody (not shown). Because no other antibody was available to detect all 17 
variants, aminoprocollagen peptidase activity was investigated in samples corresponding to a similar number of 
cells. Removal of the PNP domain (construct 2) significantly increased the enzyme activity (Fig. 35) as 
compared with the wild type enzyme (construct 1). On the contrary, removal of the fourth and the second TSPI 
repeats (constructs 3 and 5) repressed the enzymatic activity as compared with the activity measured for 
construct 2. As expected, no activity was detected for negative control constructs lacking the central domains 
(construct 11) or mutated at the catalytic site (construct 6). Mutating the potential cleavage site by furin 
(construct 7) strongly repressed, but did not abolish, the aminoprocollagen peptidase activity. Removal of the 
adjacent domains (constructs 8 -10) completely suppressed the activity. The use of chimeric enzyme indicated 
that significant levels of activity were obtained only when the metalloprotease domain and/or the other central 
domains of ADAMTS-2 are present (compare constructs 12,13, and 17 to 14-16). However, the presence of the 
C-terminal domains (spacer, TSPI 2nd, 3rd, and 4th, and the PNP domain) is also important for activity because 
their replacement by the corresponding domains of GON-1 (compare construct 12 to construct 2) or ADAMTS-
14 (compare construct 17 to construct 1) resulted in a reduced activity. 
FIGURE 3. Western blotting analysis of the various recombinant enzymes and evaluation of their 
aminoprocollagen type I peptidase activity. A extracts of 293EBNA cells stably transfected with constructs 1-17 
were analyzed by Western blotting using anti-M2 FLAG antibody. Differences in the electrophoretic mobility 
were in good correlation with both the expected protein length and the glycosylation sites that are essentially 
found in the C-terminal sequence of ADAMTS-2. B, aminoprocollagen peptidase activity in each cell extract was 




Processing of ADAMTS-2—The existence of a complex activation process for ADAMTS-2 was suggested by 
data in the literature about a few other ADAMTS and by our preliminary observations. To characterize the 
mechanisms involved in the ADAMTS-2 processing, various stably transfected 293 cells were cultured in 
different conditions. Cell layers and conditioned media were then analyzed for the presence of ADAMTS-2 
fragments by Western blotting using four antibodies (AS175, anti-M2 FLAG, anti-HA FLAG, and mAb23; see 
Fig. 1B). In a first series of experiments, cells expressing the full-length enzyme (construct 1A) were used. The 
anti-HA antibody detected six major bands (at 173, 150, 132,104, 85, and 52 kDa) in the cell layer (Fig. 4A, lane 
1). In the conditioned medium, the pattern was similar except for the absence of the 173-kDa band and the 
presence of two additional bands around 65 kDa. By using the mAb23 antibody, the overall patterns were similar 
except for the presence of a barely detectable 95-kDa product and the absence of low molecular bands (Fig. 4A, 
lane 2). By using the AS175 antibody, which is specific for an epitope in the PNP domain, the three upper bands 
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(at 173, 150, and 132 kDa) were also detected, but the 104-kDa band was not (Fig. 4A, lane 4). The 95-kDa 
product was found in association with the cell layer, and a low molecular weight product was recovered only in 
the conditioned medium. The pattern was similar with the anti-M2 FLAG antibody, except for the absence of 
immunoreactive high molecular weight product in the culture medium and for the relative intensity of bands in 
the cell layer (Fig. 4A, lane 4). These two observations are most probably related to a specific degradation of the 
M2 FLAG. 
PNGase F deglycosylation resulted in the gel shift of most ADAMTS-2 forms (Fig. 4B, compare lanes 1 and 2). 
Most interestingly, the number of bands detected before and after PNGase F treatment did not change, 
demonstrating that the various bands represent individual processed forms of ADAMTS-2 and not different 
levels of glycosylation of a more restricted number of products. Neuraminidase treatment did not alter the 
electrophoretic mobility of any bands. 
In order to determine whether the processing of the recombinant ADAMTS-2 observed in 293 cells is relevant to 
physiological processing in vivo, the electrophoretic pattern of enzyme purified from calf skin was examined 
using mAb23 (Fig. 4C). Prominent bands at 104 and 85 kDa were detected in skin extracts and fainter bands at 
150, 132, 115, and 65 kDa. All these fragments, except the 115 kDa, were also observed for the recombinant 
enzyme. 
 
FIGURE 4. Western blotting analysis of the various processing forms of ADAMTS-2. A, cells stably 
transfected with construct 1A were grown to confluence in culture. Samples of cell layer (C) and conditioned 
medium (M) were collected and analyzed by immu-noblot using four different antibodies (anti-HA, mAb23, anti-
M2, and AS175). Apparent deduced molecular sizes of ADAMTS-2 fragments are reported. Large differences in 
the electrophoretic pattern were observed. The 173-kDa band, detected by the four antibodies, was not found in 
the culture medium, suggesting that this product is either intracellular or strongly bound to the cell surface. The 
almost absence of product reacting with the anti-M2 FLAG in the culture medium probably illustrated the rapid 
degradation of either the ADAMTS-2 C-terminal end or the M2-FLAG itself. The most obvious difference was 
the presence of a prominent 104-kDa product observed only with anti-HA and mAb23, demonstrating that this 
product does not contain most of the PNP domain. B, extracts of cells expressing wild type recombinant 
ADAMTS-2 were treated with PNGase F (lane 1) or neuraminidase (lane 3). Electrophoretic mobility of the 
various bands was compared with samples incubated in identical condition without enzymes (lanes 2 and 4, 
respectively). C, the patterns of ADAMTS-2 purified from conditioned medium of cells expressing construct 1A 
or from fetal bovine skin (see "Materials and Methods" for culture conditions and purification procedures) were 
compared by Western blotting using mAb23 antibody specific for the fourth TSPI repeat (see Fig. 1). The two 
different exposure times allow the visualization of abundant (104 and 85 kDa) and minor (150, 132, and 65 kDa) 
processing forms present in both purified preparations. Only one product, with an estimated size of 115 kDa (*), 
was observed in the ADAMTS-2 preparation purified from fetal bovine skin. D, cells expressing construct 1A 
were cultured (35-mm dishes) in DMEM supplemented with 10% fetal calf serum. At confluence, medium was 
changed and replaced by 2 ml of DMEM alone (control) or supplemented with EDTA (200 µM), ZnCl2 (80 µM), 
CuCl2 (80 µM), heparin (5 µg/ml), decanoyl-RVKR furin inhibitor (40 µM), or L-Arg (50 mM). After 48 h, the 
conditioned media were collected, and the cell layer was extracted in a buffer containing 1 M NaCl. Samples, 
corresponding to 1/50 of the cell layer (C) and 1/100 of the conditioned medium (M), were analyzed by Western 
blotting using anti-HA-FLAG antibody. Deduced molecular sizes of the ADAMTS-2 processing forms are 
indicated on the right of the panels. On this blot, the bands at 177 and 173 kDa in the presence of the RVKRfurin 
inhibitor appear as a broad band. They can be individually identified on Fig. 5A 
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Treatment with various chemicals changed the relative ratio of each individual band (Fig. 4D). As an example, 
treatment of cells with EDTA significantly increased the amount of the 132-kDa band but strongly repressed the 
accumulation of the 104-kDa product (Fig. 4D, compare lanes 1 and 3). In the presence of heparin, all the 
ADAMTS-2 products were released from the cell layer compartment and accumulated in the culture medium 
(Fig. 4D, compare lanes 9 and 10). As another example, use of decanoyl-RVKR, a furin inhibitor, decreased the 
amount of the 104-kDa products and caused the accumulation of two high molecular products (177 and 173 
kDa), most probably illustrating inhibition of processing at the two identified potential cleavage sites by 
enzymes of the furin family. Finally, when the culture was supplemented with L-Arg, the band pattern partially 
mirrored the pattern observed in presence of heparin (Fig. 4D, compare lanes 10 and 14). 
To investigate further the mechanisms that generated the different ADAMTS-2 fragments and the reason why 
some recombinant enzymes do not display aminoprocollagen peptidase activity (Fig. 35), cell lines transfected 
with other constructs (6A, 7A, 14A, 15A, and 16A). Most surprisingly, a faint band was observed with an 
apparent molecular size of 153 kDa (Fig. 5A, see arrow B), suggesting that, in the absence of cleavage by furin, 
another enzyme might process ADAMTS-2 a few amino acids upstream of the cleavage site by furin. As 
observed for control construct 1A, EDTA and decanoyl-RVKR promoted the accumulation of the 132- or the 
177-kDa product, respectively. Other bands appeared fuzzy Cells expressing constructs 14A to 17A (ADAMTS-
14 and chimeric recombinant proteins constructed from part of ADAMTS-2 and -14) were also analyzed (Fig. 
55). As compared with the wild type construct 1A, the electrophoretic pattern obtained with cells expressing 
these constructs was markedly different. ADAMTS-14 (construct 14A) consisted of one major (165 kDa) and 
four minor (in the range of 95-130 kDa) products, both in control and EDTA-treated cells. With constructs 15A 
and 16A, which did not display any significant aminoprocollagen peptidase activity (Fig. 3), the electrophoretic 
pattern consisted of one main band and was not altered by culture conditions. At the opposite, the chimeric 
enzyme 17A (composed of the N terminus of ADAMTS-2 fused to the C-terminal domains of ADAMTS-14) 
displayed enzyme activity (Fig. 3) and was actively processed (Fig. 5B, lanes 5 and 10). 
FIGURE 5. Comparison of the various processing forms obtained from mutated recombinant ADAMTS-2 
and chimeric enzymes. A, cells stably transfected with construct 1 A, 6A, or 7A (respectively corresponding to 
recombinant wild type, mutated at the Zn2+-binding catalytic site or at the second cleavage site by furin) were 
cultured as described for Fig. 4D. Only data obtained from cell layer extracts are provided. In control culture 
conditions, a strong accumulation of the 150-kDa product was observed for ADAMTS-2 mutated at the catalytic 
site (compare lanes 1 and 2). In addition, the electro-phoretic mobility of most of the low molecular weight 
products is altered (compare the 104-kDa product in lane 1 with the product labeled by arrow A in lane 2). For 
ADAMTS-2 mutated at the cleavage site by furin (construct 7A, lane 3), bands at 150 and 104 are absent and 
replaced by products migrating slower (arrows B and C, respectively). In the presence of furin inhibitor [lanes 
7-9), relative accumulation of high molecular weight products (173 and 177 kDa) was observed. B, pattern of 
ADAMTS-2 (1A), ADAMTS-14 (14A), and chimeric enzymes (15A-17A) are compared in control and EDTA-
treated culture conditions. Processing products, observed by Western blotting using anti-HA antibody, are not 
observed for chimeric enzymes 15A and 16A. Intensity of products migrating at 104 kDa (lane 1) or at a close 
molecular size (lanes 2 and 5) can be correlated to the relative aminoprocollagen peptidase activity illustrated 
in Fig. 3. 
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Determination of ADAMTS-2 Cleavage Sites—Characterization of the various ADAMTS-2 products was 
performed by analyzing their electrophoretic pattern, their immunoreactivity with the various antibodies, and by 
determination of their N-terminal sequence. The high molecular size band (177 kDa) detected only in the 
presence of furin inhibitor (Fig. 5A, lanes 7-9) likely represents the full size enzyme after removal of the signal 
peptide. The relative amount of the 173-kDa product was also increased in the presence of the furin inhibitor, 
whereas the amount of the 150- and the 104-kDa product was decreased (Fig. 4D, lanes 11 and 12), suggesting 
that these two latter products are generated by processing of the 173-kDa product at the second furin cleavage 
site. Amino acid sequencing was performed on the most abundant forms of ADAMTS-2 purified from serum-
free conditioned medium and separated by SDS-PAGE (Fig. 6). The N-terminal sequence of the 150- and 104-
kDa products was determined (HAADDDY) and corresponded to the sequence found immediately downstream 
of the RRRMRR furin recognition sequence, confirming our hypothesis. Sequencing of the 132-kDa product was 
also performed, but no clear sequence was obtained because this band seemed to contain two or more 
polypeptides. This band can be detected by Western blotting using anti-M2 FLAG antibody (Fig. 4A). Therefore, 
the difference in size as compared with the 150-kDa product results only from the use of a different processing 
site at the N terminus. Based on the ADAMTS-2 amino acid sequence, this suggests that the 132-kDa form lacks 
most of the metalloproteinase domain, including the catalytic site. The N-terminal sequence of the 95- and the 
43-kDa products revealed a LNVDDNE sequence identical to a sequence found at the end of the "spacer" 
domain. Ambiguous sequences were obtained from other products. 
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FIGURE 6. SDS-PAGE analysis of purified ADAMTS-2. ADAMTS-2 (construct 1) was purified from serum-
free conditioned culture medium (see "Materials and Methods"). After electrophoresis and Coomassie Blue 
staining, the most abundant products correspond to ADAMTS-2 forms detected by Western blotting (see Fig. 
4A). This demonstrates the high level of purity of the ADAMTS-2 preparation used for amino acid sequencing. 
 
Identification of Active Forms of ADAMTS-2—In order to identify which form(s) was responsible for the 
aminoprocollagen peptidase activity, we tried to isolate individual polypeptides of ADAMTS-2. However, no 
pure fraction could be obtained because of co-purification problems (not shown). As an alternative approach, 
cells expressing the full-length enzyme (Fig. 1, construct 1A) were cultured in various conditions (see "Materials 
and Methods") to induce modifications of the ratio of the different ADAMTS-2 fragments (Fig. 4D and data not 
shown). The enzyme activity was then measured, and the individual bands were semi-quantified by Western 
blotting using AS175 and anti-HA antibodies. A correlation study comparing the relative intensity of each band 
to the overall aminoprocollagen I processing activity demonstrated that products at 173, 132, and 95 kDa and 
smaller did not process aminoprocollagen I (R ≤ 0.1) (not shown). On the contrary, a good correlation was found 
between the enzyme activity and the intensity of products at 150 kDa (R2 = 0.65) and 104 kDa (R2 = 0.81) (Fig. 
7A). Because the aminoprocollagen peptidase assay is not linear at highest enzyme activity, the shape of the 
correlation curve for the 104-kDa product probably reflects the saturation process of the assay. 
The serum-free conditioned medium of cells expressing constructs 1A, 2A, and 5A was analyzed, by Western 
blotting and enzymatic assay, in order to characterize further the role of both the 2nd TSPI repeat and the PNP 
domain (Fig. 7B). The most prominent band recovered from the conditioned medium of cells expressing 
construct 2A migrates slightly faster than the 104-kDa band of construct 1A (Fig. 7B, lane 2). 
FIGURE 7. Identification of processed forms of ADAMTS-2 displaying aminoprocollagen peptidase activity. 
A, cells expressing construct 1A were cultured (35-mm dishes) in DMEM supplemented with 10% fetal calf 
serum. At confluence, medium was changed and replaced by 2 ml of DMEM alone (control) or supplemented 
with EDTA (40, 200, or 1000 µM), ZnCl2 (16 or 80µM), CuCl2 (16 or 80µM), heparin (1, 5, or 25 µg/ml), 
decanoyl-RVKRfurin inhibitor (10, 20, or 40 µM), or L-Arg (25, 50, or 100 mM). After 48 h, the conditioned 
media were collected, and the cell layer was extracted in a buffer containing 1 M NaCI. Samples, corresponding 
to 1/50 of the cell layer and 1/100 of the conditioned medium, were analyzed by Western blotting using anti-HA-
FLAG and AS175 antibodies. The relative intensity of each band (see Fig. 4, A and D) was determined by 
scanning densitometry and correlated with enzyme activity in the corresponding sample using aminoprocollagen 
type I as substrate. Significant correlation was found only with the 150-and 104-kDa products. The highest R2 
values were obtained by linear and logarithmic regression for the 150- and 104-kDa forms, respectively, B, 
enzyme forms secreted in the conditioned culture medium of cells expressing constructs 1A, 2A, and 5A were 
characterized and quantified after Western blotting using anti-HA antibody. C, for construct 1 A, only the forms 
at 150 and 104 kDa have aminoprocollagen peptidase activity (see ,A). For cells 2 A and 5 A, there is only one 
active form at 102 and 72 kDa, respectively, allowing calculation of specific activity. The two products at 102 
(construct 2A) and 104 kDa (construct 1A) differ only by the presence of few amino acids at the C terminus of 
the 104-kDa form. Based on the hypothesis that these two products have a similar aminoprocollagen peptidase 
activity, specific activity of the 150-kDa product was calculated. 
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FIGURE 8. Compartmentalization of active forms of ADAMTS-2. Dermatosparactic calf fibroblasts were 
incubated in culture medium containing 10 µg/ml ADAMTS-2 alone (lanes 1 and 2) or ADAMTS2 and heparin 
(5 µg/ml) (lanes 3 and 4). After 6 h, medium was removed, and the cell layers were solubilized before Western 
blotting analysis using mAb23. The electrophoretic pattern obtained from duplicate cultures (lanes 1 and 2) 
illustrated the reproducibility of this technique, because both the total amount of enzyme and the relative 
abundance of the various products are identical. Moreover, the ration of the 104- and 150-kDa products is 
similar to the ratio determined for the purified enzyme before incubation (lane 5). The presence of heparin 
(lanes 3 and 4) similarly affected the binding of all the enzyme forms. 
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FIGURE 9. Autocatalytic processing of ADAMTS-2. Cells expressing construct 6A were cultured alone (lane 
1) or co-cultured with control cells (lane 2) or cells expressing the wild type construct (lane 3). Enzyme 
recovered from the cell layer was analyzed by Western blotting using anti-HA-FLAG antibody, preventing 
detection of any product resulting from the processing of the wild type enzyme (lane 4). 
 
 
This suggests that the 104-kDa product is generated by a proteolytic cleavage occurring in the beginning of the 
PNP domain, a few amino acids downstream of the C-terminal end of product 2A. Based on the hypothesis that 
these two products have a similar enzymatic activity, it was calculated that the 150-kDa product is 3-4-fold less 
active than the 104-kDa form lacking the PNP domain (Fig. 7C). Similarly, it was determined that the product at 
72 kDa (construct 5A, lacking the three C-terminal TSPI repeats and the PNP domain) is about 4-fold less active 
than the 104-kDa product. 
Compartmentalization of Active Forms of ADAMTS-2—Purified ADAMTS-2 (Fig. 8, lane 5, control) was 
added in the culture medium of dermatosparactic calf fibroblasts. After 6 h of incubation, 25% of the total 
amount of enzyme was bound to the cell layer (not shown). The ratio of the 150- and 104-kDa products 
recovered from the cell layer (Fig. 8, lanes 1 and 2) was identical to the ratio in the purified preparation before 
incubation on cells (Fig. 8, lane 5). Moreover, heparin efficiently inhibited the binding of both products (Fig. 8 
lanes 3 and 4), again suggesting a similar compartmentalization. 
Autocatalytic Processing of ADAMTS-2—Cells expressing inactive HA-flagged protein 6A were cultured 
alone or in co-culture with empty vector transfected cells or with cells expressing full-length active enzyme 
without HA-FLAG (construct 1). Western blotting analysis with anti-HA FLAG antibody was then performed to 
specifically identify processed forms of the inactive protein 6A (Fig. 9). When cultured alone or co-cultured with 
control cells (Fig. 9, lanes 1 and 2), products at 173 and 150 kDa were the two most abundant forms. In the 
presence of cells expressing the "wild type" active enzyme (Fig. 9, lane 3), no product at 104 kDa was detected, 
but a strong accumulation of the 132-kDa product was observed. These bands resulted from the processing of 
protein 6A, because the antibody failed to detect any product associated with a cell layer of cells expressing the 
construct 1 only (Fig. 9, lane 4).  
Other Substrates of ADAMTS-2—α2-Macroglobulin inhibits most proteinases by physical entrapment, upon 
cleavage within a bait region. To determine whether ADAMTS-2 can cleave and be inhibited by α2-
macroglobulin, we examined the aminoprocollagen processing of ADAMTS-2 after its preincubation with α2-
macroglobulin. ADAMTS-2 (~10 ng, as determined by Coomassie Blue staining after SDS-PAGE) was 
preincubated with α2-macroglobulin at varying concentrations (0.025 to 0.4 units). The aminoprocollagen 
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substrate was then added, and the peptidase activity was evaluated. The observed dose-response inhibition of the 
activity (Fig. 10A) was in good agreement with previous data about ADAMTS-4 (21). 
FIGURE 10. Inhibition of aminoprocollagen peptidase activity by α2-macroglobulin. A, purified ADAMTS-2 
was incubated at 37 °C with increasing amount of α2-macroglob-ulin (25 units/ml; 1-16 µl) or bovine serum 
albumin as negative control. After 1 h, the aminoprocollagen type I substrate was added, and ADAMTS-2 
activity was measured. Preincubation with bovine serum albumin did not alter the enzymatic activity. On the 
contrary, addition of α2-macroglobulin strongly inhibited aminoprocollagen peptidase activity. B, purified 
ADAMTS-2 was incubated alone (lane 1) or with α2-macroglobulin in the absence (lane 2) or presence (lane 3) 
of EDTA, an inhibitor of ADAMTS-2 activity. The band shift observed only in the presence of α2-macroglobulin 
and active enzyme (lane2) illustrated the bait and trap mechanism of inhibition. C, conditioned medium of cells 
expressing constructs 1 A, 2A, and 5A was analyzed by Western blotting using anti-HA antibody. The large 
amount of α2-macroglobulin present in the fetal calf serum is responsible for the band shift observed with the 
three forms of recombinant enzyme. 
 
FIGURE 11. α1 type V procollagen processing. A, purified fraction of homotrimeric recombinant α1(V) 
collagen synthesized by 293 cells (19) contained aminoprocollagen (pN-α1) chains and a degradation product 
(TH-α1) migrating as pepsinized α1(V) (lane 1). In the presence of purified recombinant ADAMTS-2, an 
intermediate band was observed (pNδ-α1V) (lane2), suggesting a cleavage in the "variable" domain. This 
processing product was absent in the presence of EDTA used as ADAMTS-2 inhibitor {lane 3). Type V collagen 
purified from fetal calf skin was also analyzed (lane 4). Only two bands were visualized, migrating at sizes 
corresponding to pNδ-α1 and α2V. B, schematic representation of specific cleavage sites by ADAMTS-2 and 
other α1 type V collagen processing enzymes. PARP, proline/arginine-rich protein domain. 
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Purified ADAMTS-2 was also incubated alone (Fig. 10B, lane 1) or with α2-macroglobulin in the absence (lane 
2) or the presence (lane 3) of EDTA, an inhibitor of ADAMTS-2 activity. The band shift observed only in the 
presence of α2-macroglobulin and active enzyme (Fig. 10B, lane 2) as illustrated by the bait and trap mechanism 
of inhibition. In presence of serum, which contains large amounts of α2-macroglobulin, recombinant enzymes 
1A, 2A, and 5A secreted in the conditioned culture medium were efficiently trapped, as demonstrated by the 
accumulation of large amount of high molecular weight products (Fig. 10C). 
In order to verify the processing activity on a more specific potential substrate, purified ADAMTS-2 was 
incubated with aminoprocollagen type V, a fibrillar collagen that is N-terminally processed in vivo. Recombinant 
α1 type V collagen homotrimer synthesized by 293 cells was used (20). After separation on SDS-PAGE (Fi. 
11A, lane 1), this collagen appeared as two bands corresponding to aminoprocollagen V (pN-α1(V)), containing 
all the N-terminal domains (proline/arginine-rich protein domain, the variable region, and the short triple helix), 
and to a degradation product (TH-α1(V)) consisting of the full-length triple helix domain. After incubation with 
active ADAMTS-2, another product of intermediate size was observed (Fig. 11A, lane 2), indicative of a 
cleavage in the variable domain of type V pNcollagen. This pattern was similar in the absence or presence of 
DTT. The N-terminal sequence of this product was determined (ANQDTIYE) and was identical to a sequence 
located at the C-terminal end of the variable domain (SEIG-PGMPANQDTIYE). This defines a new cleavage 
site for ADAMTS-2 (PA versus the (A/P)Q described in procollagens I-III) in a different three-dimensional 
context (the variable domain rather than a sequence located between two collagen domains, Fig. 11B). As control 
for the in vivo relevance of this cleavage site, type V collagen purified from fetal calf skin was analyzed by 
Western blotting (Fig. 11A, lane 4). A product presenting the same electrophoretic mobility as the pNδ-α1(V) 
was observed together with another band consisting of the α2V chain. More interestingly, no other product was 
detected, indicative of the absence of α1V processed at the published BMP-1 cleavage site (Fig. 11B). The 
moderate increase of the amount of TH-α1V, or of a product of similar size, after incubation with ADAMTS-2 
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FIGURE 12. Characterization of the various forms of ADAMTS-2. Characterization of the N- and C-terminal 
sequences and the domain structure of the different ADAMTS-2 products was performed by analyzing 
complementary data from electrophoretic mobility, Western blotting, and microsequencing. Estimated molecular 
sizes are reported on the left. The presence of specific epitopes and N-terminal sequence, when determined, is 
indicated on the schematic representation of each form. Dotted lines illustrate regions where processing is 
supposed to be performed but was not unambiguously confirmed by protein sequencing. 
 
DISCUSSION 
ADAMTS are complex enzymes containing numerous well defined domains. Recent studies (16, 22, 23) indicate 
that post-translational processing can alter ADAMTS-4 activity and specificity. Cleavage of recombinant 
ADAMTS-2 has also been reported (6). However, the relevance to the in vivo situation and the involvement of 
the processing for the regulation of ADAMTS-2 activity were not investigated. 
Requirement of the Individual Domains for Aminoprocollagen Peptidase Activity—Recent studies have 
investigated the implication of some domains for the enzymatic activity of ADAMTS-1 and -4 (16, 24-26). In 
our work, we systematically evaluated the function of several domains of ADAMTS-2 by investigating the 
aminoprocollagen peptidase activity of the various forms of recombinant enzyme, either wild type, mutated, or 
lacking specific sequences. Removal of the PNP domain strongly and reproducibly increased the enzyme 
activity, as compared with the full-size enzyme. This suggested a negative regulatory function for this domain, 
either directly, by interfering with the catalytic activity of the metalloproteinase domain, or indirectly, by altering 
the recognition and the binding of the substrate. On the contrary, the second and fourth TSP1 repeat were 
positive regulators because their removal decreased the aminoprocollagen peptidase activity. Most interestingly, 
form 5 (lacking the three last TSP1 repeats and the C-terminal domain) was still significantly active, suggesting 
that full activity is provided by cooperation between several domains. Most ADAM and ADAMTS enzymes are 
synthesized as a "pro-" zymogen form that has to be cleaved by furin or related enzymes to display full activity. 
When the potential cleavage site by furin was mutated, only low but still significant aminoprocollagen peptidase 
activity was measured, confirming the involvement of furin cleavage for the regulation of ADAMTS-2 activity 
but suggesting also that either an alternative processing pathway is able to activate the pro-ADAMTS-2 or that 
the full size pro-enzyme can display activity as described for ADAMTS-13 (27). Recombinant enzymes lacking 
different sequences between the pro- and the metalloproteinase domains were efficiently synthesized and 
secreted but exhibited no activity. This result suggests that the pro-domain is not only responsible for the 
repression of enzyme activity but is also essential for the correct folding of the protein as observed for other 
enzymes (28). 
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It was demonstrated, by evaluation of the aminoprocollagen peptidase activity of forms 1-5, that the C-terminal 
part of ADAMTS-2 is required for full enzyme activity, probably for an efficient recognition and binding of the 
substrate (see above). In order to verify whether substrate specificity is also dictated by these domains or, on the 
contrary, by the metalloprotease domain itself or other domains lying in the central part of ADAMTS-2, 
chimeric enzymes were produced by domains swapping with either GON-1, a C. elegans ADAMTS, or 
ADAMTS-14 (5), an enzyme closely related to ADAMTS-2 but exhibiting only low aminoprocollagen peptidase 
activity in vitro. Among the different chimeric enzymes, only the form 17 (containing the N-terminal part of 
ADAMTS-2 fused to the C-terminal part of ADAMTS-14) exhibited high aminoprocollagen peptidase activity, 
although lower than activity measured with the wild type form 1. 
These data altogether suggest the following: (i) the pro-domain is required for the correct folding of ADAMTS-2 
but has to be cleaved by furin for full enzyme activity; (ii) the PNP domain acts as a negative regulator for 
aminoprocollagen processing; (iii) the central domains of ADAMTS-2 are essential for aminoprocollagen type I 
processing; (iv) TSP1 repeats 2 and 4 are required for full enzyme activity, illustrating probably their 
involvement in substrate recognition or binding; and (v) TSP1 repeats of other ADAMTS, even of the closely 
related ADAMTS-14, are not able to fulfill completely the function of the corresponding domains of ADAMTS-
2, suggesting finely regulated cooperative interactions between the various domains of the enzyme. 
Characterization of the ADAMTS-2 Maturation Products—The characterization of the various maturation 
products was performed by integrating various complementary data (Fig. 12). The 177-, 173-, and 150-kDa 
products start, respectively, at the end of the signal peptide, at the first or the second furin cleavage site, and 
extend to the M2-FLAG (Fig. 12). No clear sequence was obtained for the 132-kDa product, but it possibly 
corresponds to the 118-kDa band reported to also contain two individual products, generated by processing in the 
metalloprotease domain (6). Size discrepancy between the two studies may be related to differences in the level 
of glycosylation, due to the fact that the two enzymes are from different origins (bovine and human) and to slight 
differences in the conditions used for SDS-PAGE analysis. Sequence of the N terminus of the 104-kDa product 
demonstrated a cleavage at the second cleavage site by furin, as for the 150-kDa product. Because the 104-kDa 
product is not recognized by antiserum AS175 specific for the C terminus of ADAMTS-2, it strongly suggests 
that it is produced by removal of most of the PNP domain, a region that was shown to negatively regulate 
activity of ADAMTS-2 (see above). This is further confirmed by SDS-PAGE analysis showing a similar size for 
the 104-kDa product and the most abundant form of protein 2A (102 kDa), lacking the PNP domain. The 95- and 
43-kDa products are generated by cleavage at an identical site, at the end of the spacer domain. Based on the low 
activity displayed by recombinant enzyme form 5, this processing results probably in the production of an 
enzyme lacking significant aminoprocollagen peptidase activity. A mechanism of inactivation of 
aminoprocollagen peptidase activity or the release of biologically active TSP1 repeats are potential functions of 
ADAMTS-2 processing at this site. Localization of other fragments was essentially deduced from Western 
blotting data experiments because these fragments were retained during the purification process, assuming also 
the presence of at least one of the C-terminally located TSP1 repeats that are required for efficient purification 
using heparin-Sepharose chromatography (data not shown; see Ref. 29). 
TABLE  ONE 
Comparison of sequences corresponding to the end of the α1 type V N-terminal prodomain in various species 
The arrows ( ↓ ) indicate the site of cleavage by ADAMTS-2 in human recombinant α1 type V homotrimer and in 
identical or similar sequences in other species. The position of the cleavage site relative to the short triple helix, 
which is composed of 17 GXY repeats, and to main triple helix, is highly conserved. Localization and sequence of the 
potential cleavage sites between the two triple helical domains (A-Q) are also strictly conserved, aa indicates amino 
acids. 
Human, mouse, rat and hamster 
GPGMP ↓ ANQDT, 33 aa, 17 GXY repeats; 21 aa, AQESQAQ, 12 aa, central triple helix 
 
Chicken (Gallus gattus) 
GPGMP ↓ ANQDT, 33 aa, 17 GXY repeats; 21 aa, AQEAQAQ, 12 aa, central triple helix 
In order to determine whether the maturation process observed for recombinant enzyme produced in 293 cells is 
relevant to the in vivo situation, active enzyme was purified from calf skin and characterized by Western 
blotting. The most prominent form of native enzyme has an estimated molecular mass of 104 kDa, thus 
migrating with the same mobility as the most abundant recombinant form. Products at 150, 132, and 85 kDa 
were also observed in both preparations, whereas another fragment, 118 kDa, was only present in the calf skin 
preparation. These observations suggested that the in vitro processing of recombinant ADAMTS-2 as observed 
in 293 cells is highly similar to the in vivo situation, indicating that this cell line represents a valuable model to 
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study the regulation of ADAMTS-2 maturation. Because 293 cells and calf skin fibroblasts are not expected to 
express a common panel of highly specific enzymes, this multiple processing is likely to be performed by 
ubiquitous enzymes or by an autocatalytic process. 
ADAMTS-2 processing was further investigated in vitro by using cells expressing recombinant enzyme mutated 
at the catalytic site. The catalytically inactive ADAMTS-2 accumulated as a 150-kDa form with no 104-kDa 
form. Because the point mutation introduced in the catalytic site is not expected to modify the three-dimensional 
structure of the enzyme, this observation strongly suggested that the 104-kDa form results largely from an 
autocatalytic processing of the 150-kDa form. Because many activation processes require "co-factors" or are 
operated at the cell surface, a co-culture experiment was set up to investigate this hypothesis. In these conditions, 
a wild type active enzyme promotes a strong accumulation of the 132-kDa product from inactive protein 6A. 
However, the 104-kDa product was not detected. These data suggest that the generation of the 132-kDa product 
is an intermolecular autocatalytic process that probably occurs at the cell surface, whereas the 104-kDa form 
would result from an intramolecular cleavage. Alternatively, the possibility of an intermolecular processing that 
would be performed only during the secretion process, preventing its detection by the co-culture model, cannot 
be ruled out. 
Identification of ADAMTS-2 Maturation Products Displaying Enzymatic Activity—Selective purification 
of each individual maturation product could not be efficiently performed because they displayed similar 
properties during the purification procession. To overcome this problem, cells expressing the wild type 
ADAMTS-2 were cultured in conditions known to modify the relative abundance of the various forms of the 
enzyme that were correlated to the enzyme activity. Inverse correlation, suggestive of an inhibitory function, was 
not found for any product. The only significant positive correlations were established with the 150-kDa form 
(linear regression, R2 = 0.65) and the 104-kDa form (logarithmic regression, R2 = 0.81). The specific activity of 
the two products was measured. It indicated that the 104-kDa form is 3-4-fold more active than the 150-kDa 
product, again illustrating the inhibitory function of the PNP domain. These results are in agreement with other 
data. For example, the shape of the correlation curve of the 104-kDa product (Fig. 7A) probably illustrates 
saturation of the aminoprocollagen peptidase assay. Because this assay is linear only in presence of low 
enzymatic activity, this provides indirect evidence that the 104-kDa form is responsible for most of the activity. 
This is also suggested by our observations showing that active enzyme purified from skin is essentially 
recovered in a 104-kDa form. 
Compartmentalization of Active Forms of ADAMTS-2—A previous study (22) demonstrated that removal of 
the C-terminal spacer domain of ADAMTS-4 affected its compartmentalization. In this study, the binding 
properties of the 104- and 150-kDa products were found to be similar, both in absence or presence of heparin, 
demonstrating that the most critical domain for efficient immobilization is not located in the PNP domain. 
Preliminary analysis (not shown) of the various forms of ADAMTS-2 truncated at the C terminus (constructs 1-
5) suggests that efficient binding both to the cell layer and to the heparin-Sepharose matrix is largely mediated 
by the second TSPI repeat. 
Identification of Additional Substrates—Activity of ADAMTS-2 is strongly influenced by the three-
dimensional structure of the substrate. For example, aminoprocollagen processing is inhibited in vitro and in vivo 
when the native triple helical structure of type I procollagen is altered (20, 30). To investigate whether 
ADAMTS-2 is able to process other structurally unrelated proteins, we used the α2-macroglobulin broad 
spectrum substrate. Cleavage of the bait region of α2-macroglob-ulin induces a large conformational change, 
resulting in the entrapment and the inhibition of the cleaving enzyme. Such a mechanism has been described for 
several types of proteases, including ADAM and ADAMTS (21, 31). Incubation of ADAMTS-2 with α2-
macroglobulin dose-dependently inhibits aminoprocollagen peptidase activity, demonstrating that ADAMTS-2 
can cleave substrates other than fibrillar collagens. Moreover, preliminary results obtained using recombinant 
enzymes 2A and 5A suggest that the C-terminal domains do not regulate the cleavage of α2-macroglobulin by 
ADAMTS-2. 
Type V collagen is a quantitatively minor fibrillar collagen that participates in the regulation of type I collagen 
fibrillogenesis. It is most widely found in vivo as an [α1(V)] 2 α2(V) heterotrimer, but other forms are also 
present such as an [α1(V)]3 homotrimer or cross-type heterotrimers composed of type V and type XI chains (for 
review, see Ref. 7). Characterization of the processing of the aminopropeptide of type V procollagen chains has 
led to confusing and sometime conflicting results (9,32-35), possibly because of the existence of different 
cleavage sites and tissue- or cell-dependent diversity in the level of processing. Moreover, extraction and 
purification of native type V collagen are low yield processes, hampering the characterization as an intact 
molecule and explaining why most recent works have been performed by using recombinant type V collagen (9 -
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12). Although the consensus sequence for cleavage by ADAMTS-2 (AQ) is present at the expected localization 
as compared with procollagen types I-III (between the short and the long triple helical domains) and is highly 
conserved between species (TABLE ONE), there was no direct experimental evidence for type V 
aminopropeptide processing at this site. This hypothesis was verified by incubating purified recombinant 
aminoprocollagen type V with recombinant ADAMTS-2. Processing was observed, but at a more N-terminal 
sequence corresponding to the end of the variable region. The cleavage site (P ↓ A) is not identical but has some 
similarity to the cleavage site reported previously for ADAMTS-2 ((P/A) ↓ Q). In addition, the sequence in this 
region is highly conserved among the different species, suggesting the physiological relevance of this finding. 
Furthermore, the size of the band obtained after ADAMTS-2 cleavage is similar to the size previously 
determined for the α1(V) chain extracted with acetic acid from tissues and referred to as the "intact chain" (36, 
37). As additional evidence, Western blotting analysis of type V collagen purified from fetal calf skin 
demonstrated the presence of only two products, one presenting the same electrophoretic mobility as the pNδ-
α1(V) and another consisting in α2V chain. Most interestingly, no other product was detected, strongly 
suggesting the absence of α1V processed at the published BMP-1 cleavage site. Based on the high sequence 
homology between the two collagen domains, the apparent absence of cleavage at the AQ consensus cleavage 
site for ADAMTS-2 was surprising (TABLE ONE). This may illustrate a true absence of processing at this site 
in vivo or that another enzyme, such as ADAMTS-3 or -14, is responsible for the processing in vivo. 
Alternatively, the site of type V procollagen processing may vary and be developmentally or tissue-specifically 
regulated. Finally, because aminoprocollagen peptidase activity of ADAMTS-2 is strongly dependent on the 
three-dimensional structure of the substrates (20,30), it may be hypothesized that processing of the 
aminopropeptide, by cleavage between the two triple-helical domains, would be observed only with perfectly 
folded recombinant type V procollagen. Considering that only a fraction of the recombinant type V procollagen 
is perfectly folded, the moderate increase of the amount of a product migrating as TH-α1(V), which was 
sometimes observed after incubation with ADAMTS-2, possibly illustrates this hypothesis. 
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